Review highlights curcumin's potential neuroprotective role against Alzheimer's, suggesting implications for therapy.
Key Points
Curcumin shows promise in reducing neurotoxicity from amyloid beta, preventing aggregate formation, and enhancing cognition and behavior.
In vitro studies reveal curcumin's ability to limit oxidative damage, while in vivo rodent trials indicate decreased amyloid plaques and tau hyperphosphorylation.
Despite its therapeutic potential, curcumin faces bioavailability challenges and the need for large-scale human trials, limiting clinical application.
Future innovations like nano formulations may enhance curcumin's efficacy, paving the way for synergistic therapies against Alzheimer's disease.